Tom Frusher
Chief Commercial Officer Arcturis Data
Seminars
Wednesday 25th February 2026
From Fragmented Data to Decision-Grade Evidence: Unlocking the Potential of UK RWD to Accelerate and De-Risk Development and Commercialisation
10:00 am
- Explore how growing receptivity to RWE from key UK regulators is driving demand for UK RWD, creating new opportunities for pharma to engage with greater confidence
- Learn how a growing network of leading UK health systems is powering a unique research database to deliver fit-for-purpose, near real time, multi-modal datasets for impactful evidence generation
- Consider select case studies demonstrating how clinically informed, longitudinal and linked UK RWD unlocks new RWE opportunities in an era of precision medicine and patient centricity
